Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$13.01 - $15.77 $53,341 - $64,657
4,100 New
4,100 $56,000
Q2 2022

Aug 12, 2022

SELL
$7.06 - $13.97 $11.4 Million - $22.5 Million
-1,608,162 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $33.5 Million - $42.2 Million
804,081 Added 100.0%
1,608,162 $77.6 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $8.48 Million - $12.2 Million
204,081 Added 34.01%
804,081 $38.8 Million
Q4 2020

Feb 17, 2021

BUY
$36.08 - $56.47 $21.6 Million - $33.9 Million
600,000 New
600,000 $32.3 Million
Q3 2020

Nov 12, 2020

SELL
$33.26 - $40.48 $405,772 - $493,855
-12,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$24.21 - $31.02 $295,362 - $378,444
12,200 New
12,200 $378,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.83B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.